Her primary areas of study are Immunology, T-cell receptor, Molecular biology, T cell and Antigen. Her Immunology study frequently draws parallels with other fields, such as Adenosine deaminase deficiency. Giulia Casorati has researched T-cell receptor in several fields, including Gene transfer, CD3, Leukemia and Endogeny.
Her Molecular biology research is multidisciplinary, relying on both Genetics, Gene rearrangement and Gene product. Her biological study spans a wide range of topics, including Cancer vaccine, Naked DNA and Vaccination. Her IL-2 receptor research includes elements of Interleukin 12 and Interleukin 21.
Her main research concerns Immunology, Antigen, T-cell receptor, Natural killer T cell and T cell. Immunology and Cytotoxic T cell are frequently intertwined in her study. She has included themes like Receptor, Cancer research and Tumor antigen in her Antigen study.
Giulia Casorati combines subjects such as Molecular biology, In vitro, CD3 and Alpha with her study of T-cell receptor. Her Natural killer T cell research incorporates elements of Acquired immune system, Autoimmunity and Cell biology. Her T cell research is multidisciplinary, incorporating elements of Gene rearrangement, Heteroduplex, Cell therapy, Clone and Polyclonal antibodies.
Her scientific interests lie mostly in Immunology, Natural killer T cell, CD1D, Cancer research and T cell. Her Immunology study focuses mostly on Leukemia, CD8, Bone marrow, Antigen-presenting cell and CD1. Her research integrates issues of Dendritic cell, Mononuclear phagocyte system, Antigen presentation and Cell biology in her study of Natural killer T cell.
Her Cancer research research incorporates themes from CD40 and Immunotherapy. Her work is dedicated to discovering how T cell, Antigen are connected with Cell therapy and other disciplines. Her research in T-cell receptor intersects with topics in Antigenic Specificity, Antibody, Nucleic acid and Molecular biology.
Giulia Casorati mainly investigates Immunology, Natural killer T cell, CD1D, Leukemia and Cancer research. Her study involves T cell and Acquired immune system, a branch of Immunology. Her work deals with themes such as Effector, Transforming growth factor beta and Antigen-presenting cell, which intersect with Natural killer T cell.
She interconnects Cell, Cellular differentiation, microRNA and Signal transduction, Cell biology in the investigation of issues within CD1D. The Cancer research study combines topics in areas such as Somatic cell, CD40, Antigen and Immunotherapy. Her work on CD8, Human leukocyte antigen and Epitope as part of general Antigen research is frequently linked to Gene mutation, bridging the gap between disciplines.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Gene therapy in peripheral blood lymphocytes and bone marrow for ADA- immunodeficient patients
Claudio Bordignon;Luigi D. Notarangelo;Nadia Nobili;Giuliana Ferrari.
CD1d-mediated Recognition of an α-Galactosylceramide by Natural Killer T Cells Is Highly Conserved through Mammalian Evolution
Laurent Brossay;Mariacristina Chioda;Nicolas Burdin;Yasuhiko Koezuka.
Journal of Experimental Medicine (1998)
Expression of two T cell receptor alpha chains: dual receptor T cells
Elisabetta Padovan;Giulia Casorati;Paolo Dellabona;Stefan Meyer.
An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells.
Paolo Dellabona;Elisabetta Padovan;Giulia Casorati;Manfred Brockhaus.
Journal of Experimental Medicine (1994)
Editing T cell specificity towards leukemia by zinc finger nucleases and lentiviral gene transfer
Elena Provasi;Pietro Genovese;Angelo Lombardo;Zulma Magnani.
Nature Medicine (2012)
CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.
Grazia Galli;Sandra Nuti;Simona Tavarini;Luisa Galli-Stampino.
Journal of Experimental Medicine (2003)
Peripheral Blood Lymphocytes as Target Cells of Retroviral Vector-Mediated Gene Transfer
Fulvio Mavilio;Giuliana Ferrari;Silvano Rossini;Nadia Nobili.
Invariant NKT cells sustain specific B cell responses and memory
Grazia Galli;Paola Pittoni;Elena Tonti;Carmine Malzone.
Proceedings of the National Academy of Sciences of the United States of America (2007)
Selection by two powerful antigens may account for the presence of the major population of human peripheral gamma/delta T cells.
G De Libero;G Casorati;C Giachino;C Carbonara.
Journal of Experimental Medicine (1991)
Immune reconstitution in ADA-SCID after PBL gene therapy and discontinuation of enzyme replacement.
Alessandro Aiuti;Sergio Vai;Alessandra Mortellaro;Giulia Casorati.
Nature Medicine (2002)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: